Prenatal Care Practice Questions

Q: A pregnant woman presents with red degeneration of a fibroid. What is the management?

Conservative management. **Explanation:** **Red degeneration** (necrobiosis) is the most common complication of fibroids during pregnancy, typically occurring in the second trimester. It is caused by rapid growth of the fibroid due to high estrogen levels, leading to the tumor outgrowing its blood supply. This results in venous thrombosis, hemorrhage, and infarction within the fibroid. **1. Why Conservative Management is Correct:** Red degeneration is a **self-limiting condition**. The primary goal is to manage the acute symptoms—severe abdominal pain, localized tenderness, low-grade fever, and leukocytosis—until the episode subsides, which usually takes 4–7 days. Management includes **bed rest, intravenous hydration, and analgesics** (NSAIDs or narcotics). Surgery is avoided because the increased pelvic vascularity during pregnancy poses a high risk of life-threatening hemorrhage. **2. Why Other Options are Incorrect:** * **Myomectomy:** Generally contraindicated during pregnancy due to the risk of massive hemorrhage and miscarriage/preterm labor. It is only considered in rare cases of pedunculated fibroid torsion. * **Hysterectomy:** This is an extreme measure and is not indicated for a benign, self-limiting condition like red degeneration. * **Termination of Pregnancy:** Red degeneration does not harm the fetus directly, and symptoms resolve with medical management; therefore, ending the pregnancy is unnecessary. **Clinical Pearls for NEET-PG:** * **Pathology:** Characterized by a "beefy red" appearance and a fishy odor due to the presence of peripheral hemolytic pigment. * **Investigation of Choice:** Ultrasound (shows a cystic/complex mass); however, diagnosis is primarily **clinical**. * **Analgesia:** While NSAIDs are used, they should be avoided after 32 weeks to prevent premature closure of the ductus arteriosus.

Q: A pregnant female infected with rubella virus at 22 weeks of gestation. What is the recommended management?

Reassurance. The correct answer is **D. Reassurance**. ### **Explanation** The risk of Congenital Rubella Syndrome (CRS) is highly dependent on the gestational age at the time of maternal infection. The period of maximum vulnerability is the first trimester (up to 12 weeks), where the risk of fetal infection is approximately 80–90%. After **20 weeks of gestation**, the risk of congenital malformations is virtually **zero**. While the virus can still cross the placenta, it does not cause the classic triad of CRS (cataracts, sensorineural deafness, and cardiac defects) because organogenesis is complete. Therefore, if a woman is infected at 22 weeks, the management is simple reassurance as the pregnancy can proceed normally without fear of teratogenicity. ### **Why Other Options are Incorrect** * **A. Rubella vaccination:** The Rubella vaccine (MMR) is a **live-attenuated vaccine** and is strictly contraindicated during pregnancy due to the theoretical risk of fetal infection. * **B. Rubella immunoglobulin:** Post-exposure prophylaxis with Ig does not prevent fetal infection and is only considered if a non-immune pregnant woman is exposed in early pregnancy and strictly refuses termination. It has no role at 22 weeks. * **C. Antiviral drug:** There is no specific effective antiviral therapy for Rubella infection. ### **NEET-PG High-Yield Pearls** * **Critical Period:** Risk of CRS is highest (<12 weeks: 80-90%), decreases (13–16 weeks: 15%), and becomes negligible after **20 weeks**. * **Gregg’s Triad:** Cataracts, Sensorineural hearing loss (most common), and PDA (Peripheral Pulmonary Artery Stenosis is also common). * **Diagnosis:** Maternal IgM antibodies or a four-fold rise in IgG titers. * **Vaccination Strategy:** If a woman is found to be non-immune during pregnancy, vaccinate in the **immediate postpartum period**. Advise avoiding pregnancy for 1 month (28 days) after vaccination.

Q: A mother with a history of antenatal fetal death due to neural tube defect in her first child presents for preconception counseling. What is the recommended daily dosage of folic acid (in micrograms/day) to be prescribed?

4000. **Explanation:** The primary goal of periconceptional folic acid supplementation is to prevent **Neural Tube Defects (NTDs)**. The dosage is determined by the patient's risk profile: 1. **High-Risk Patients (Correct Answer D):** Women with a **previous history** of a child with an NTD, or if either parent has an NTD, are at high risk for recurrence. The recommended dosage is **4 mg (4000 mcg) per day**. This should ideally start at least 1–3 months before conception and continue through the first trimester. 2. **Low-Risk Patients (Option C):** For women with no prior history of NTDs, the standard prophylactic dose is **0.4 mg (400 mcg) per day**. 3. **Options A and B:** These represent 4 mcg and 40 mcg respectively, which are sub-therapeutic doses and insufficient for preventing congenital malformations. **High-Yield Clinical Pearls for NEET-PG:** * **Timing:** Folic acid is most effective when started **pre-conceptionally** because the neural tube closes by the **28th day** of gestation (often before a woman knows she is pregnant). * **Other High-Risk Indications for 4 mg:** Mothers with diabetes mellitus (pre-gestational) or those taking anti-epileptic drugs (e.g., Valproate, Carbamazepine) also require the higher 4 mg dose. * **Mechanism:** Folic acid is essential for DNA synthesis and methylation; deficiency leads to failure of the neural folds to fuse. * **Associated Lab Finding:** Elevated **Alpha-Fetoprotein (AFP)** in maternal serum or amniotic fluid is a marker for open NTDs.

Q: What is the recommended treatment for pregnant women with syphilis?

Parenteral penicillin. **Explanation:** The treatment of choice for syphilis in pregnancy is **Parenteral Penicillin G**. This is the only documented effective therapy that treats both the mother and the fetus (as it crosses the placenta) and prevents congenital syphilis. * **Why Parenteral Penicillin is correct:** Penicillin G is bactericidal against *Treponema pallidum*. For primary, secondary, or early latent syphilis, a single IM dose of **Benzathine Penicillin G (2.4 million units)** is recommended. For late latent syphilis or syphilis of unknown duration, three doses at weekly intervals are required. * **Why the others are incorrect:** * **Tetracycline/Doxycycline:** These are contraindicated in pregnancy as they are teratogenic (causing dental discoloration and affecting fetal bone growth). * **Oral Penicillin:** Oral formulations do not achieve the sustained, therapeutic serum levels necessary to reliably cure the infection or reach the fetus. * **Aminoglycosides:** These are ineffective against *T. pallidum* and carry risks of fetal ototoxicity. **High-Yield Clinical Pearls for NEET-PG:** 1. **Penicillin Allergy:** If a pregnant woman is allergic to penicillin, she **must** undergo **desensitization** followed by treatment with Penicillin G. No other alternative (like Erythromycin or Azithromycin) is considered reliable for preventing congenital syphilis. 2. **Jarisch-Herxheimer Reaction:** This is an acute febrile reaction occurring within 24 hours of starting treatment. In pregnancy, it can trigger preterm labor or fetal distress; however, treatment should not be delayed. 3. **Screening:** Universal screening is recommended at the first prenatal visit using non-treponemal tests (VDRL/RPR).

Q: Hypospadias in a baby is caused by maternal use of which of the following drugs?

Clomiphene. **Explanation:** The correct answer is **Clomiphene (Option C)**. **Medical Concept:** Clomiphene citrate is a Selective Estrogen Receptor Modulator (SERM) commonly used for ovulation induction. While generally considered safe when used as directed, its use has been epidemiologically linked to an increased risk of **hypospadias** in male offspring. The underlying mechanism is thought to involve the drug's long half-life; residual clomiphene may interfere with the estrogen-androgen balance during the critical period of urethral fold fusion (usually between 8–14 weeks of gestation), leading to the displacement of the urethral meatus. **Analysis of Incorrect Options:** * **A. Diethylstilbestrol (DES):** Historically associated with **Clear Cell Adenocarcinoma of the vagina** and structural uterine anomalies (T-shaped uterus) in female offspring, and epididymal cysts or cryptorchidism in males, but not primarily hypospadias. * **B. Tolbutamide:** A first-generation sulfonylurea. While poorly controlled maternal diabetes is teratogenic, tolbutamide specifically is more associated with neonatal hypoglycemia rather than structural penile defects. * **D. Clobazam:** A benzodiazepine. Maternal use of benzodiazepines is more traditionally linked to "Floppy Infant Syndrome" or, controversially, orofacial clefts, but not hypospadias. **High-Yield NEET-PG Pearls:** * **Hypospadias** is the most common congenital anomaly of the penis. * **Clomiphene** is the first-line treatment for WHO Group II ovulation disorders (e.g., PCOS). * Other drugs linked to hypospadias include **Finasteride** (due to 5-alpha reductase inhibition) and maternal exposure to **Valproate**. * **Surgical correction** for hypospadias is ideally performed between **6 to 12 months** of age. Circumcision should be avoided as the prepuce is needed for repair.

Q: What is the best method for diagnosing Trisomy-21 during the second trimester of pregnancy?

Amniocentesis. ### Explanation The diagnosis of chromosomal abnormalities like Trisomy 21 (Down Syndrome) is categorized into **Screening tests** (which calculate risk) and **Diagnostic tests** (which provide a definitive karyotype). **Why Amniocentesis is the Correct Answer:** Amniocentesis is the **gold standard diagnostic test** in the second trimester (typically performed between 15–20 weeks). It involves ultrasound-guided aspiration of amniotic fluid containing fetal desquamated cells. these cells are cultured for **karyotyping** or analyzed via **FISH/QF-PCR**, providing a definitive diagnosis with >99% accuracy. **Analysis of Incorrect Options:** * **A. Triple marker estimation:** This is a **screening test** performed between 15–20 weeks (measuring AFP, hCG, and uE3). It only provides a probability of risk, not a diagnosis. * **B. Nuchal skin fold thickness:** This is a second-trimester **soft marker** on ultrasound (significant if ≥6 mm). While it increases the suspicion of Down Syndrome, it is not diagnostic. (Note: Do not confuse this with *Nuchal Translucency*, which is measured in the first trimester). * **C. Chorionic villus sampling (CVS):** While CVS is a definitive diagnostic test, it is performed in the **first trimester** (10–13 weeks). It is generally avoided in the second trimester due to technical difficulty and the availability of amniocentesis. **High-Yield Clinical Pearls for NEET-PG:** * **Best Screening Test (Overall):** Combined Test (NT scan + PAPP-A + hCG) in the first trimester. * **Best Diagnostic Test (First Trimester):** Chorionic Villus Sampling (CVS). * **Most Common Ultrasound Marker (Second Trimester):** Increased Nuchal Fold thickness. * **Amniocentesis Risk:** The procedure-related risk of miscarriage is approximately 0.5% (1 in 200). * **Quadruple Marker:** Includes the Triple marker components plus **Inhibin-A** (increased in Trisomy 21).

Q: What change is typically noticed in diastolic blood pressure during pregnancy?

Decline of 5-10 mm of Hg. **Explanation:** The correct answer is **B. Decline of 5-10 mm of Hg.** **1. Why the correct answer is right:** During pregnancy, systemic vascular resistance (SVR) decreases significantly due to the vasodilatory effects of **progesterone** and increased production of local vasodilators like **nitric oxide** and prostacyclin. Additionally, the development of the low-resistance uteroplacental circulation acts as an "arteriovenous shunt." While systolic blood pressure (SBP) shows little change, **diastolic blood pressure (DBP)** typically begins to fall in the first trimester, reaching its nadir (lowest point) at **16–24 weeks** of gestation. The average decline is approximately **5–10 mm Hg**. This physiological drop is essential to accommodate the 40–50% increase in blood volume without causing hypertension. **2. Why the incorrect options are wrong:** * **Options C & D (Elevation):** Blood pressure does not normally rise during a healthy pregnancy. An elevation of ≥140/90 mm Hg is diagnostic of hypertensive disorders of pregnancy (e.g., Gestational Hypertension or Preeclampsia). * **Option A (Decline of 10-20 mm Hg):** While a significant drop can occur in some individuals, a 10-20 mm Hg decline is more characteristic of the change in **Mean Arterial Pressure (MAP)** rather than the specific average decline of the diastolic component alone. **Clinical Pearls for NEET-PG:** * **Nadir:** DBP is lowest at mid-pregnancy (20-24 weeks) and returns to pre-pregnancy levels by term. * **Pulse Pressure:** Since DBP falls more than SBP, the pulse pressure (SBP minus DBP) **increases** during pregnancy. * **Positioning:** BP is lowest when the patient is in the **left lateral position** (due to relief of aortocaval compression) and highest when sitting. * **Cardiac Output:** Increases by 30-50%, peaking early at 20-24 weeks.

Q: A woman became pregnant 1 month after receiving the MMR vaccine, despite being advised to avoid pregnancy. What advice should the doctor give the patient?

Wait and watch. **Explanation:** The MMR vaccine is a **live-attenuated vaccine** containing Measles, Mumps, and Rubella strains. Historically, there has been a theoretical concern that the live Rubella virus in the vaccine could cross the placenta and cause **Congenital Rubella Syndrome (CRS)** if administered just before or during pregnancy. **Why "Wait and Watch" is correct:** Current clinical guidelines (CDC and WHO) recommend avoiding pregnancy for **28 days (1 month)** after MMR vaccination. However, extensive registry data of women who inadvertently received the vaccine shortly before or during pregnancy have shown **zero cases of CRS**. While the vaccine virus can infect the fetus, it has not been shown to be teratogenic. Therefore, accidental vaccination is **not** an indication for termination of pregnancy. The patient should be reassured and monitored with routine prenatal care. **Analysis of Incorrect Options:** * **B & D:** These are incorrect because the risk of fetal malformation from the vaccine strain is purely theoretical and has never been documented in clinical practice. Termination is never "mandatory" for MMR exposure. * **C:** While the risk is indeed "low" (effectively zero), suggesting termination "may be considered" creates unnecessary anxiety for a situation where no clinical evidence of harm exists. **NEET-PG High-Yield Pearls:** * **Interval:** The recommended gap between MMR vaccination and conception is **4 weeks (28 days)**. * **Contraindication:** Pregnancy is a general contraindication for all live vaccines (except in specific high-risk scenarios like Yellow Fever). * **Postpartum:** MMR is safe and recommended for non-immune women in the immediate postpartum period, even if breastfeeding. * **Household contacts:** It is safe to vaccinate children or household members of a pregnant woman with MMR; the virus is not transmitted from the vaccinee.

Q: What is the earliest sign of pregnancy visualized on transvaginal sonography (TVS)?

Gestational sac. The earliest sonographic evidence of pregnancy is the **Gestational Sac**. In a normal intrauterine pregnancy, it can be visualized via Transvaginal Sonography (TVS) as early as **4.5 to 5 weeks** of gestation (when the Mean Sac Diameter is approximately 2–3 mm). It appears as a small, eccentric fluid collection within the endometrium, often surrounded by the "double decidual sign." ### Why the other options are incorrect: * **Yolk Sac:** This is the first structure to appear *inside* the gestational sac. It is typically visible via TVS at **5 to 5.5 weeks**. Its presence confirms an intrauterine pregnancy and rules out a pseudogestational sac. * **Fetal Pole:** The embryo (fetal pole) becomes visible adjacent to the yolk sac at approximately **6 weeks** via TVS. * **Fetal Heart Sounds:** Cardiac activity is the first sign of a living embryo and is usually detected when the fetal pole reaches 5 mm in length, typically around **6 to 6.5 weeks** via TVS. ### High-Yield Clinical Pearls for NEET-PG: * **Discriminatory Zone:** This is the level of serum β-hCG at which a gestational sac should definitely be visible. For TVS, this is **1,500–2,000 mIU/mL** (for TAS, it is 6,500 mIU/mL). Failure to see a sac above these levels suggests ectopic pregnancy or miscarriage. * **Order of Appearance (TVS):** Gestational Sac (5 wks) → Yolk Sac (5.5 wks) → Fetal Pole/Heartbeat (6 wks). * **Rule of Thumb:** Transvaginal sonography (TVS) is generally **1 week ahead** of Transabdominal sonography (TAS) in detecting early pregnancy landmarks.

Q: Nuchal translucency is best measured at which gestational age?

11-13 weeks. **Explanation:** Nuchal Translucency (NT) refers to the subcutaneous collection of fluid behind the fetal neck. It is a critical screening marker for chromosomal abnormalities (especially Trisomy 21) and structural defects like congenital heart disease. **Why 11–13 weeks is correct:** The optimal window for NT measurement is **11 weeks to 13 weeks and 6 days** (specifically when the Crown-Rump Length is between **45 mm and 84 mm**). * **Physiological Basis:** Before 11 weeks, the fetus is too small for technically accurate measurement. After 14 weeks, the fetal lymphatic system typically develops enough to drain the excess fluid, causing the translucency to disappear or evolve into a nuchal fold, rendering the test unreliable for first-trimester screening. **Analysis of Incorrect Options:** * **A (8–10 weeks):** The fetus is too small, and the lymphatic system is not yet sufficiently developed to reflect pathological fluid accumulation. * **C & D (15–20 weeks):** This is the window for the **Second Trimester Anomaly Scan**. During this period, we measure **Nuchal Fold Thickness** (abnormal if >6 mm), not Nuchal Translucency. **High-Yield Clinical Pearls for NEET-PG:** * **Cut-off Value:** An NT measurement **>3.5 mm** is generally considered abnormal and associated with Down Syndrome, Turner Syndrome, and Cardiac defects. * **Combined Screening:** NT is often combined with maternal serum markers (**PAPP-A and β-hCG**) to increase the detection rate for Down Syndrome to ~90%. * **Nasal Bone:** Absence of the nasal bone during the 11–13 week scan is another strong soft marker for Trisomy 21.

Question 1

A pregnant woman presents with red degeneration of a fibroid. What is the management?

Accepted Answer

Conservative management

Answer

Myomectomy

Answer

Hysterectomy

Answer

Termination of pregnancy

Question 2

A pregnant female infected with rubella virus at 22 weeks of gestation. What is the recommended management?

Accepted Answer

Reassurance

Answer

Rubella vaccination

Answer

Rubella immunoglobulin intramuscularly

Answer

Antiviral drug

Question 3

A mother with a history of antenatal fetal death due to neural tube defect in her first child presents for preconception counseling. What is the recommended daily dosage of folic acid (in micrograms/day) to be prescribed?

Accepted Answer

4000

Answer

4

Answer

40

Answer

400

Question 4

What is the recommended treatment for pregnant women with syphilis?

Accepted Answer

Parenteral penicillin

Answer

Tetracycline

Answer

Oral penicillin

Answer

Aminoglycosides

Question 5

Hypospadias in a baby is caused by maternal use of which of the following drugs?

Accepted Answer

Clomiphene

Answer

Diethyl stilbesterol

Answer

Tolbutamide

Answer

Clobazam

Question 6

What is the best method for diagnosing Trisomy-21 during the second trimester of pregnancy?

Accepted Answer

Amniocentesis

Answer

Triple marker estimation

Answer

Nuchal skin fold thickness measurement

Answer

Chorionic villus sampling

Question 7

What change is typically noticed in diastolic blood pressure during pregnancy?

Accepted Answer

Decline of 5-10 mm of Hg

Answer

Decline of 10-20 mm of Hg

Answer

Elevation of 10-20 mm of Hg

Answer

Elevation of 5-10 mm of Hg

Question 8

A woman became pregnant 1 month after receiving the MMR vaccine, despite being advised to avoid pregnancy. What advice should the doctor give the patient?

Accepted Answer

Wait and watch

Answer

Termination of pregnancy is mandatory

Answer

Low risk; termination of pregnancy may be considered

Answer

High risk of anomalies; consider termination

Question 9

What is the earliest sign of pregnancy visualized on transvaginal sonography (TVS)?

Accepted Answer

Gestational sac

Answer

Fetal pole

Answer

Yolk sac

Answer

Fetal heart sounds

Question 10

Nuchal translucency is best measured at which gestational age?

Accepted Answer

11-13 weeks

Answer

8-10 weeks

Answer

15-17 weeks

Answer

18-20 weeks

Prenatal Care — MCQs

Prenatal Care — MCQs

On this page

Practice by Chapter

Want unlimited practice?